Science Explorer Back to mapMap
Discussion
Company · San Carlos · United States

BioCardia (United States)

biocardia.comROR OpenAlex
Research works
7
▲ 97% vs 2018-21
Citations
188
27.5 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
15%
world 40%
International
27%
world 18%
BioCardia (United States)

Not ranked overall: BioCardia (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BioCardia (United States) work in?

In all years, 62% of research at BioCardia (United States) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (62%), Biochemistry, Genetics and Molecular Biology (19%), Materials Science (9%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 62.2% of its workMedicine: 4 fractional works · 62.2% of its workSurgery: 2 fractional works · 22.4% of its workGenetics: 1 fractional works · 19.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 15.0% of its workOncology: 0 fractional works · 4.8% of its workLife Sciences: 2 fractional works · 23.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 18.6% of its workMolecular Biology: 1 fractional works · 15.8% of its workGenetics: 0 fractional works · 2.8% of its workNeuroscience: 0 fractional works · 4.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 4.8% of its workPhysical Sciences: 1 fractional works · 14.4% of its workMaterials Science: 1 fractional works · 8.8% of its workBiomaterials: 1 fractional works · 8.8% of its workEngineering: 0 fractional works · 5.6% of its workElectrical and Electronic Engineering: 0 fractional works · 4.8% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workALL ITS WORKBioCardia (UnitedStates)7fractional works, all years
Life Sciences23%Physical Sciences14%Health Sciences62%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine462.2%
    1. Biochemistry, Genetics and Molecular Biology118.6%
    2. Neuroscience04.8%
    1. Materials Science18.8%
    2. Engineering05.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at BioCardia (United States)?

Ranked on the quality score, Peter A. Altman lead among researchers whose main affiliation is BioCardia (United States).

  1. 1 Peter A. Altman United States · #1,019,557 worldwide 3.3k citations · 38 works
All ranked researchers at BioCardia (United States)

What are the most cited papers from BioCardia (United States)?

The most cited paper from BioCardia (United States) is "Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy" (Adam R. Williams, Barry H. Trachtenberg, Darcy L. DiFede Velazquez et al., 2011), with 319 citations. Next come "An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure" (135) and "Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy" (135).

Most cited papers
#PaperReleasedCitations
1 Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy Adam R. Williams, Barry H. Trachtenberg, Darcy L. DiFede Velazquez et al. · Circulation Research Open access 18 Mar 2011 319
2 An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer et al. · Circulation Research 22 Feb 2013 135
3 Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy Barry H. Trachtenberg, Darcy L. DiFede Velazquez, Adam R. Williams et al. · American Heart Journal Mar 2011 135
4 Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study) Luís de la Fuente, Simon H. Stertzer, Julio Argentieri et al. · American Heart Journal 20 Jun 2007 58
5 The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post–myocardial infarction heart failure: Trial rationale and study design Amish N. Raval, Thomas D. Cook, Henricus J. Duckers et al. · American Heart Journal 3 Apr 2018 28
All 17 most cited papers, with filters and sorting

Which research topics does BioCardia (United States) publish most on?

By volume in 2022-now: Cardiac electrophysiology and arrhythmias, Fuel Cells and Related Materials, Neuroscience and Neural Engineering and Tissue Engineering and Regenerative Medicine.

Cardiac electrophysiolog…0Cardiac electrophysiology and arrhythmias: 0 fractional worksFuel Cells and Related M…0Fuel Cells and Related Materials: 0 fractional worksNeuroscience and Neural …0Neuroscience and Neural Engineering: 0 fractional worksTissue Engineering and Regenerative Medicine: 0 fractional worksMesenchymal stem cell research: 0 fractional worksPluripotent Stem Cells R…0Pluripotent Stem Cells Research: 0 fractional works
Cardiology and Cardiovascular MedicineElectrical and Electronic EngineeringCellular and Molecular NeuroscienceSurgery2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  2. 2 Fuel Cells and Related Materials Electrical and Electronic Engineering 0 works
  3. 3 Neuroscience and Neural Engineering Cellular and Molecular Neuroscience 0 works
  4. 4 Tissue Engineering and Regenerative Medicine Surgery 0 works
  5. 5 Mesenchymal stem cell research Genetics 0 works
  6. 6 Pluripotent Stem Cells Research Molecular Biology 0 works
  7. 7 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 0 works
  8. 8 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available15.2%not open84.8%

World: 40% of research is openly available.

with international co-authors26.8%domestic only73.2%

World: 18% is written across borders.

How has BioCardia (United States)'s research output changed?

Output in 2022-2025 was 97% higher than in 2018-2021.

2005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioCardia (United States) as a percentage of every work published that year, 0.0000021% in 2022.

0.000020%0.000040%0.000060%BioCardia (United States)0.000023% in 202320102020

Fractional works of BioCardia (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Carlos

All research institutions in San Carlos

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioCardia (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.